{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:24:35Z","timestamp":1781231075435,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1007\/s11910-001-0009-7","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T06:05:03Z","timestamp":1183010703000},"page":"137-143","source":"Crossref","is-referenced-by-count":19,"title":["Advances in biology and treatment of childhood brain tumors"],"prefix":"10.1007","volume":"1","author":[{"given":"Alyssa T.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"9_CR1","volume-title":"Pathology of Tumors of the Nervous System","author":"DS Russell","year":"1977","unstructured":"Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, edn 4. Baltimore: Williams and Wilkins; 1977.","edition":"edn 4"},{"key":"9_CR2","volume-title":"Pathology and Genetics of Tumors of the Central Nervous System","author":"P Kleihues","year":"1997","unstructured":"Kleihues P, Cavenee W. Pathology and Genetics of Tumors of the Central Nervous System. Lyon, France: International Agency for Research on Cancer; 1997."},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","volume":"81","author":"RJ Packer","year":"1994","unstructured":"Packer RJ, Sutton LN, Elterman R, et al.: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994, 81:690\u2013698.","journal-title":"J Neurosurg"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, et al.: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol 1999, 17:832\u2013845. This is a large, prospective, clinical trial that demonstrates improved outcome for children with medulloblastoma, based both on extent of disease and treatment protocol.","journal-title":"J Clin Oncol"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0360-3016(99)00177-7","volume":"45","author":"J Grill","year":"1999","unstructured":"Grill J, Renaux VK, Bulteau C, et al.: Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Physics 1999, 45:137\u2013145.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","volume":"17","author":"RJ Packer","year":"1999","unstructured":"Packer RJ, Goldwein J, Nicholson HS, et al.: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children\u2019s Cancer Group Study. J Clin Oncol 1999, 17:2127\u20132136. This large, prospective, clinical trial demonstrates the ability to reduce the dose of craniospinal radiation in patient\u2019s with average-risk medulloblastoma.","journal-title":"J Clin Oncol"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G","volume":"88","author":"AT Reddy","year":"2000","unstructured":"Reddy AT, Janss AJ, Phillips PC, et al.: Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 2000, 88:2189\u20132193. This study suggests that supratentorial neuroectodermal tumor is a more aggressive disease than medulloblastoma.","journal-title":"Cancer"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.1073\/pnas.91.26.12867","volume":"91","author":"RA Segal","year":"1994","unstructured":"Segal RA, Goumnerova LC, Kwon YK, et al.: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci U S A 1994, 91:12867\u201312871.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR9","first-page":"711","volume":"59","author":"JY Kim","year":"1999","unstructured":"Kim JY, Sutton ME, Lu DJ, et al.: Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 1999, 59:711\u2013719. This is a very exciting article that gives a clear demonstration of how TrkC expression induces apoptosis, and may explain why TrkC is associated with improved outcome.","journal-title":"Cancer Res"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1523\/JNEUROSCI.17-02-00530.1997","volume":"17","author":"Y Muragaki","year":"1997","unstructured":"Muragaki Y, Chou TT, Kaplan DR, et al.: Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J Neurosci 1997, 17:530\u2013542.","journal-title":"J Neurosci"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1074\/jbc.275.1.565","volume":"275","author":"TT Chou","year":"2000","unstructured":"Chou TT, Trojanowski JQ, Lee VM: A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma. J Biol Chem 2000, 275:565\u201370. This article suggests a signaling pathway in medulloblastoma apoptosis.","journal-title":"J Biol Chem"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1073\/pnas.96.20.11519","volume":"96","author":"B Krynska","year":"1999","unstructured":"Krynska B, Del Valle L, Croul S, et al.: Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A 1999, 96:11519\u201311524. The work suggests that JC virus plays a role in medulloblastoma oncogenesis.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3171\/jns.1997.86.6.0943","volume":"86","author":"TE Merchant","year":"1997","unstructured":"Merchant TE, Haida T, Wang MH, et al.: Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997, 86:943\u2013949.","journal-title":"J Neurosurg"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1227\/00006123-199510000-00008","volume":"37","author":"IF Pollack","year":"1995","unstructured":"Pollack IF, Gerszten PC, Martinez AJ, et al.: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995, 37:655\u2013666.","journal-title":"Neurosurgery"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00172482","volume":"13","author":"JK Chiu","year":"1992","unstructured":"Chiu JK, Woo SY, Ater J, et al.: Intracranial ependymoma in children: analysis of prognostic factors. J Neuro-Oncol 1992, 13:283\u2013290.","journal-title":"J Neuro-Oncol"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01053933","volume":"15","author":"JJ Kovalic","year":"1993","unstructured":"Kovalic JJ, Flaris N, Grigsby PW, et al.: Intracranial ependymoma long term outcome, patterns of failure. J Neuro-Oncol 1993, 15:125\u2013131.","journal-title":"J Neuro-Oncol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0360-3016(99)00414-9","volume":"46","author":"B Timmermann","year":"2000","unstructured":"Timmermann B, Kortmann RD, Kuhl J, et al.: Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88\/89 and HIT 91. Int J Radiat Oncol Biol Physics 2000, 46:287\u2013295.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199306173282401","volume":"328","author":"PK Duffner","year":"1993","unstructured":"Duffner PK, Horowitz ME, Krischer JP, et al.: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors [comments]. N Engl J Med 1993, 328:1725\u20131731.","journal-title":"N Engl J Med"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1097-0142(19900801)66:3<557::AID-CNCR2820660325>3.0.CO;2-8","volume":"66","author":"JW Goldwein","year":"1990","unstructured":"Goldwein JW, Glauser TA, Packer RJ, et al.: Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 1990, 66:557\u2013563.","journal-title":"Cancer"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1097-0142(19851001)56:7<1497::AID-CNCR2820560703>3.0.CO;2-7","volume":"56","author":"CL Sexauer","year":"1985","unstructured":"Sexauer CL, Khan A, Burger PC, et al.: Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study. Cancer 1985, 56:1497\u20131501.","journal-title":"Cancer"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006394407245","volume":"45","author":"MK Gornet","year":"1999","unstructured":"Gornet MK, Buckner JC, Marks RS, et al.: Chemotherapy for advanced CNS ependymoma. J Neuro-Oncol 1999, 45:61\u201367.","journal-title":"J Neuro-Oncol"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<870::AID-CNCR18>3.0.CO;2-I","volume":"88","author":"SL Stafford","year":"2000","unstructured":"Stafford SL, Pollock BE, Foote RL, et al.: Stereotactic radiosurgery for recurrent ependymoma. Cancer 2000, 88:870\u2013875. This study demonstrates the effectiveness of treating recurrent ependymoma with radiosurgery, and suggests it may have a role in up-front treatment.","journal-title":"Cancer"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-4608(99)00080-1","volume":"115","author":"AM Vagner-Capodano","year":"1999","unstructured":"Vagner-Capodano AM, Zattara-Cannoni H, Gambarelli D, et al.: Cytogenetic study of 33 ependymomas. Cancer Genet Cytogenet 1999, 115:96\u201399.","journal-title":"Cancer Genet Cytogenet"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.bjc.6690822","volume":"81","author":"TJ Hulsebos","year":"1999","unstructured":"Hulsebos TJ, Oskam NT, Bijleveld EH, et al.: Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. Br J Cancer 1999, 81:1150\u20131154. This article suggests a possible tumor suppressor gene for ependymoma.","journal-title":"Br J Cancer"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00165101","volume":"7","author":"R Sposto","year":"1989","unstructured":"Sposto R, Ertel IJ, Jenkin RD, et al.: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neuro-Oncol 1989, 7:165\u2013177.","journal-title":"J Neuro-Oncol"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3","volume":"77","author":"CR Freeman","year":"1996","unstructured":"Freeman CR, Bourgouin PM, Sanford RA, et al.: Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 1996, 77:555\u2013562.","journal-title":"Cancer"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006360222643","volume":"44","author":"RI Jakacki","year":"1999","unstructured":"Jakacki RI, Siffert J, Jamison C, et al.: Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neuro-Oncol 1999, 44:77\u201383. This study demonstrated extreme toxicity with concurrent high-dose chemotherapy and radiation.","journal-title":"J Neuro-Oncol"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K","volume":"88","author":"E Bouffet","year":"2000","unstructured":"Bouffet E, Raquin M, Doz F, et al.: Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 2000, 88:685\u2013692.","journal-title":"Cancer"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1200\/JCO.2000.18.6.1246","volume":"18","author":"A Broniscer","year":"2000","unstructured":"Broniscer A, Leite CC, Lanchote VL, et al.: Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol 2000, 18:1246\u20131253.","journal-title":"J Clin Oncol"},{"key":"9_CR30","first-page":"3569","volume":"19","author":"M Huncharek","year":"1999","unstructured":"Huncharek M, Wheeler L, McGarry R, Geschwind JF: Chemotherapy response rates in recurrent\/progressive pediatric glioma; results of a systematic review. Anticancer Res 1999, 19:3569\u20133574. This large review article includes results of 27 treatment trials.","journal-title":"Anticancer Res"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.1989.70.6.0853","volume":"70","author":"EG Shaw","year":"1989","unstructured":"Shaw EG, Daumas-Duport C, Scheithauer BW, et al.: Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989, 70:853\u2013861.","journal-title":"J Neurosurg"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/1097-0142(19900701)66:1<6::AID-CNCR2820660103>3.0.CO;2-F","volume":"66","author":"CA North","year":"1990","unstructured":"North CA, North RB, Epstein JA, et al.: Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 1990, 66:6\u201314.","journal-title":"Cancer"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1042-3680(18)30822-2","volume":"1","author":"BL Guthrie","year":"1990","unstructured":"Guthrie BL, Laws ERJr: Supratentorial low-grade gliomas. Neurosurg Clin North Am 1990, 1:37\u201348.","journal-title":"Neurosurg Clin North Am"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00337-5","volume":"45","author":"M Fuss","year":"1999","unstructured":"Fuss M, Hug EB, Schaefer RA, et al.: Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Physics 1999, 45:1117\u20131126. This article suggests that proton beam therapy may have a role in treating low-grade gliomas.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J, et al.: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997, 86:747\u2013754.","journal-title":"J Neurosurg"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1005736104205","volume":"32","author":"MD Prados","year":"1997","unstructured":"Prados MD, Edwards MS, Rabbitt J, et al.: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-Oncol 1997, 32:235\u2013241.","journal-title":"J Neuro-Oncol"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/jns.1997.86.3.0446","volume":"86","author":"M Matsutani","year":"1997","unstructured":"Matsutani M, Sano K, Takakura K, et al.: Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 1997, 86:446\u2013455.","journal-title":"J Neurosurg"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0360-3016(97)00330-1","volume":"39","author":"PH Hardenbergh","year":"1997","unstructured":"Hardenbergh PH, Golden J, Billet A, et al.: Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Physics 1997, 39:419\u2013426.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0360-3016(99)00375-2","volume":"46","author":"TE Merchant","year":"2000","unstructured":"Merchant TE, Sherwood SH, Mulhern RK, et al.: CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Physics 2000, 46:1171\u20131176. This study suggests excellent outcome for patients treated with radiation alone.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00006123-199912000-00002","volume":"45","author":"LN Sutton","year":"1999","unstructured":"Sutton LN, Radcliffe J, Goldwein JW, et al.: Quality of life of adult survivors of germinomas treated with craniospinal irradiation. Neurosurgery 1999, 45:1292\u20131297.","journal-title":"Neurosurgery"},{"key":"9_CR41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s003810050279","volume":"14","author":"M Fouladi","year":"1998","unstructured":"Fouladi M, Grant R, Baruchel S, et al.: Comparison of survival outcomes in patients with intracranial germinomas treated with radiation alone versus reduced-dose radiation and chemotherapy. Childs Nervous Syst 1998, 14:596\u2013601.","journal-title":"Childs Nervous Syst"},{"key":"9_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1006367316168","volume":"44","author":"Y Shibamoto","year":"1999","unstructured":"Shibamoto Y, Sasai K, Kokubo M, Hiraoka M: Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy. J Neuro-Oncol 1999, 44:181\u2013185.","journal-title":"J Neuro-Oncol"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0360-3016(94)90162-7","volume":"28","author":"BG Fuller","year":"1994","unstructured":"Fuller BG, Kapp DS, Cox R: Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Int J Radiat Oncol Biol Physics 1994, 28:229\u2013245.","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1006395719917","volume":"44","author":"T Tada","year":"1999","unstructured":"Tada T, Takizawa T, Nakazato F, et al.: Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue. J Neuro-Oncol 1999, 44:71\u201376. This small study suggests improved survival for patient\u2019s with nongerminous germ cell tumor treated with high-dose chemotherapy and radiation.","journal-title":"J Neuro-Oncol"},{"key":"9_CR45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3171\/jns.2000.92.2.0249","volume":"92","author":"RJ Packer","year":"2000","unstructured":"Packer RJ, Raffel C, Villablanca JG, et al.: Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration. J Neurosurg 2000, 92:249\u2013254. The study demonstrates safety of intracerebral inoculation of viral vector gene therapy in pediatric patients.","journal-title":"J Neurosurg"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.gt.3301205","volume":"7","author":"JM Markert","year":"2000","unstructured":"Markert JM, Medlock MD, Rabkin SD, et al.: Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 2000, 7:687\u2013694. This study demonstrates safety of genetically altered herpes virus as an oncolytic agent in the treatment of brain tumors.","journal-title":"Gene Ther"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0009-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-001-0009-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0009-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:23Z","timestamp":1559435063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-001-0009-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0009-7","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}